The World Drug Safety Congress Europe brings together over 700 key thought leaders to explore the top challenges within pharmacovigilance.
This year’s agenda will explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches, and discuss how to tackle the challenges of social media and drug safety legislation globally.
Visit Qinecsa at booth 40 to learn how we’re bringing together best-in-class technology and scientific expertise so we can connect life science companies to the right drug safety solutions.
Attend Dr Andrew Rut’s presentation ‘Transforming Data into Decisions’ on Sept 28 at 15:35 to learn how digital solutions can be leveraged to generate a true picture of Benefit-Risk across subgroups and individuals, enabling more relevant communication and decision making.
Get in touch to book a meeting with us at the event and find out how Qinecsa can help you take drug safety solutions to the next level!
